Millennium Management

Millennium Management Portfolio holdings

AUM $112B
1-Year Return 13.71%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Quarter Return
+3.49%
1 Year Return
+13.71%
3 Year Return
+41.74%
5 Year Return
+76.27%
10 Year Return
+245.84%
AUM
$78.1B
AUM Growth
+$6.71B
Cap. Flow
+$2.15B
Cap. Flow %
2.75%
Top 10 Hldgs %
8.97%
Holding
5,931
New
1,185
Increased
1,836
Reduced
1,830
Closed
663

Sector Composition

1 Technology 16.42%
2 Healthcare 14.95%
3 Financials 12.02%
4 Consumer Discretionary 11.76%
5 Industrials 10.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FNHC
3976
DELISTED
FedNat Holding Company Common Stock
FNHC
$640K ﹤0.01%
+154,145
New +$640K
TSHA icon
3977
Taysha Gene Therapies
TSHA
$818M
$639K ﹤0.01%
30,165
+9,040
+43% +$191K
PTRS
3978
DELISTED
Partners Bancorp Common Stock
PTRS
$639K ﹤0.01%
+79,504
New +$639K
AIN icon
3979
Albany International
AIN
$1.71B
$638K ﹤0.01%
7,147
-26,765
-79% -$2.39M
BBH icon
3980
VanEck Biotech ETF
BBH
$348M
$638K ﹤0.01%
+3,162
New +$638K
EPIX icon
3981
ESSA Pharma
EPIX
$8.91M
$638K ﹤0.01%
22,318
-17,651
-44% -$505K
TLYS icon
3982
Tilly's
TLYS
$60.6M
$635K ﹤0.01%
39,736
-67,344
-63% -$1.08M
IMNM icon
3983
Immunome
IMNM
$808M
$634K ﹤0.01%
+36,670
New +$634K
NISN icon
3984
NiSun International Enterprise Development Group
NISN
$16.8M
$633K ﹤0.01%
5,914
+4,311
+269% +$461K
EVOJ
3985
DELISTED
Evo Acquisition Corp. Class A Common Stock
EVOJ
$633K ﹤0.01%
+65,223
New +$633K
TBT icon
3986
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$279M
$632K ﹤0.01%
+33,576
New +$632K
HSII icon
3987
Heidrick & Struggles
HSII
$1.04B
$631K ﹤0.01%
14,161
-13,631
-49% -$607K
GHL
3988
DELISTED
Greenhill & Co., Inc.
GHL
$631K ﹤0.01%
40,548
-29,166
-42% -$454K
ESE icon
3989
ESCO Technologies
ESE
$5.41B
$630K ﹤0.01%
6,717
-4,092
-38% -$384K
DNTH icon
3990
Dianthus Therapeutics
DNTH
$1.48B
$627K ﹤0.01%
4,007
+1,298
+48% +$203K
ELTX icon
3991
Elicio Therapeutics
ELTX
$174M
$626K ﹤0.01%
4,806
+1,480
+44% +$193K
FET icon
3992
Forum Energy Technologies
FET
$319M
$624K ﹤0.01%
26,584
+3,939
+17% +$92.5K
DKDCU
3993
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
$624K ﹤0.01%
+60,433
New +$624K
VEA icon
3994
Vanguard FTSE Developed Markets ETF
VEA
$175B
$623K ﹤0.01%
12,100
-32,094
-73% -$1.65M
AVTX icon
3995
Avalo Therapeutics
AVTX
$134M
$621K ﹤0.01%
66
+61
+1,220% +$574K
IDEX
3996
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$621K ﹤0.01%
1,750
-5,021
-74% -$1.78M
EOLS icon
3997
Evolus
EOLS
$439M
$619K ﹤0.01%
48,908
-180,074
-79% -$2.28M
NVVE icon
3998
Nuvve Holding Corp
NVVE
$4.62M
$619K ﹤0.01%
+112
New +$619K
BCYC
3999
Bicycle Therapeutics
BCYC
$478M
$618K ﹤0.01%
+20,363
New +$618K
CNQ icon
4000
Canadian Natural Resources
CNQ
$66.7B
$618K ﹤0.01%
34,765
-469,235
-93% -$8.34M